The PSDF will be offset by a higher proportion of some drugs

"Some of the preparations for various diseases have so far been 100% and 80% or 90% matched, and the PSDF's budget savings have brought the majority of diseases to 100%", said Friday the Minister of Health. Veryga.

Deputy Minister of Health Kristina Garuolienė said that there is essentially a group of diseases where 100% of the drugs will not be reimbursed. – Cardiac and Circulatory Diseases

"The drugs for the treatment of hypertension and other heart diseases will be reimbursed up to 90% and until now they have been compensated at the level of 80%, "said K. Garuolienė. , for diseases of the circulatory system and in cases of disorders of lipoprotein metabolism, instead of 80%. set at 90%

The estimated additional cost of the Mandatory Health Insurance Fund (PSFF) for these drugs would be about 3.6 million.

For infectious and parasitic diseases, endocrine diseases, nervous system, ocular, digestive, urobad, pregnancy and childbirth, conbad malformations, organ transplants and, in some cases, Compensation levels of 80 and 90% It is expected to increase up to 100%.

According to the department, this would cost an additional $ 4.6 million.

The Ministry of Health (SAM) says that the new drugs in the price list on Thursday, based on a new reciprocal drug, will be cheap, However, manufacturers are criticizing the shortening of the list of reimbursable drugs.

According to SAM, in the new price list, the "ceiling" of the premium, 100%. The compensation premium can not exceed EUR 4.11

The Ministry also claims that the new pricing of medicines and the reduction of prices of pharmaceutical companies have saved a considerable amount of extra budgetary and administrative costs. patients, thus starting to compensate for the active substances. New Active Ingredients: These drugs are intended for the treatment of end-stage pain in cancer, chronic lymphocytic leukemia, Hodgkin lymphoma, asthma, BRAF-free melanoma, ovarian and / or ovarian cancer, lung and bad cancer and other diseases. 19659007] The ministry maintains that all active substances consuming patients remain in price, but pharmaceutical manufacturers point out that there will be fewer drugs. According to the Association of Pharmaceutical Manufacturers, 200,000 people will have to change their habits. With the introduction of the new procedure, manufacturers have decreased, while in the tariff, nearly a quarter of the compensatory drugs left to 200,000 patients have been treated with cardiovascular, pulmonary, nervous system diseases central, oncology and others. patients. They need to change drugs, "said Rasa Bričkienė, director of the Pharmaceutical Manufacturers Association.

The Minister of Health said that until now, a proportion of patients were paying five euros more per month.

"The fact that the patient has a habit of buying a brand name, where two active substances are compressed into a tablet is more of a psychological condition but not a substance active or treatment, "said the minister at a press conference. 19659002]

"I had some patients sit on a site to take and compare the prices of the drugs to treat blood pressure, where it is compressed into one tablet and two tablets, but the same dose, the same active substance , the patient does not change

"There are patients who do not want to remove both pills for the first time," said the minister.

A good five euros, especially retirees, for whom the five euros are a lot of money, – said A. Veryga

Pharmacists say a total of 1950 drugs were listed in the initial price list, while 1584 remained on the approved list because 366 drugs did not match requirements Agnė Gaižauskienė, director of the Innovative Pharmaceutical Industry Association, said the new price list limits the allocation of more than 50 drugs without generic badogues to new patients. [19659002] Agnė Gaižauskienė, Director of the Innovative Pharmaceutical Industry Association. ]

"We agree that the optimization of drug prices is necessary to ensure the best possible access to advanced treatment, but this should not affect the right of patients to receive the drug. However, we see that the new order does not guarantee that – a large part of patients will be limited to the right to receive the necessary medicines, "said A. Gaižauskienė

According to the press release of the Association, some of the patients will decrease the payment of drugs. will have to change their usual medications. In addition, some drugs will only be available for continuous treatment, which means that new patients will no longer be able to receive the same medication.